Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
|
|
H-CYTE, INC. (MDVX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2022 |
4
| Lynch Frederick J (10% Owner) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Exercised (in-or-at-the-money) 8,321,785 options to buy
@ $0.014, valued at
$116.5k
Acquired 8,321,785 options to buy
@ $0.014, valued at
$116.5k
|
|
| 02/25/2022 |
4
| FARRIOR J REX III (10% Owner) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Exercised 693,477 options to buy
@ $0.014, valued at
$9.7k
Granted 693,477 options to buy
@ $0.014, valued at
$9.7k
|
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
3
| Lynch Frederick J (10% Owner) has filed a Form 3 on H-CYTE, INC. |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Horne William E (Director) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Acquired 3,655,382 preferred shares
@ $0.014, valued at
$51.2k
Acquired 1,869,667 options to buy
@ $0.014, valued at
$26.2k
|
|
| 04/14/2021 |
4/A
| Daniel Jeremy (CFO) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Granted 5,000,000 options to buy
@ $0.07, valued at
$350k
|
|
| 04/12/2021 |
4
| Daniel Jeremy (CFO) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Granted 5,000,000 options to buy
@ $0.07, valued at
$350k
|
|
| 04/12/2021 |
3
| Daniel Jeremy (CFO) has filed a Form 3 on H-CYTE, INC. |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Monteleone Raymond (Director) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Granted 3,000,000 options to buy
@ $0.07, valued at
$210k
|
|
| 04/05/2021 |
4
| Horne William E (Director) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Granted 2,000,000 options to buy
@ $0.07, valued at
$140k
|
|
| 04/05/2021 |
4
| Greif Robert Smith (CEO) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Granted 34,000,000 options to buy
@ $0.07, valued at
$2.4M
|
|
| 04/05/2021 |
3
| Monteleone Raymond (Director) has filed a Form 3 on H-CYTE, INC. |
| 03/15/2021 |
4
| FARRIOR J REX III (10% Owner) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Converted 15,518,111 shares
@ $0.4082, valued at
$6.3M
Converted 15,518,111 preferred shares
@ $0.4082, valued at
$6.3M
Acquired 7,488,063 preferred shares
@ $0.014, valued at
$104.8k
Acquired 7,488,063 options to buy
@ $0.014, valued at
$104.8k
Acquired 7,142,857 preferred shares
@ $0.014, valued at
$100k
|
|
| 10/23/2020 |
3
| Greif Robert Smith (President and C.E.O.) has filed a Form 3 on H-CYTE, INC. |
| 06/26/2020 |
4
| Horne William E (CEO) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Granted 4,368,278 shares
@ $0.39, valued at
$1.7M
Granted 4,368,278 warrants
@ $0 |
|
| 02/24/2020 |
3
| FARRIOR J REX III (10% Owner) has filed a Form 3 on H-CYTE, INC. |
| 01/21/2020 |
4
| Yurkowsky Michael (Director) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Bought 8,100 shares
@ $0.1294, valued at
$1k
Bought 5,000 shares
@ $0.135, valued at
$675
Bought 1,900 shares
@ $0.1348, valued at
$256.1
Bought 10,000 shares
@ $0.145, valued at
$1.5k
|
|
| 12/20/2019 |
4
| Yurkowsky Michael (Director) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Bought 27,500 shares
@ $0.14, valued at
$3.9k
Bought 7,500 shares
@ $0.11, valued at
$825 |
|
| 12/20/2019 |
3
| Yurkowsky Michael (Director) has filed a Form 3 on H-CYTE, INC. |
| 09/18/2019 |
3/A
| Horne William E (CEO) has filed a Form 3/A on H-CYTE, INC. |
| 09/18/2019 |
4
| Horne William E (CEO) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Granted 4,225,634 shares
@ $0 |
|
| 09/18/2019 |
4
| Horne William E (CEO) has filed a Form 4 on H-CYTE, INC.|
Txns:
| Granted 250,000 options
@ $0.4, valued at
$100k
|
|
| 09/18/2019 |
3
| Horne William E (CEO) has filed a Form 3 on H-CYTE, INC. |
| 05/31/2019 |
3/A
| Horne William E (CEO) has filed a Form 3/A on Medovex Corp. |
| 04/29/2019 |
4
| Horne William B (CEO) has filed a Form 4 on Medovex Corp.|
Txns:
| Granted 4,225,634 shares
@ $0 |
|
| 04/29/2019 |
4
| Horne William B (CEO) has filed a Form 4 on Medovex Corp.|
Txns:
| Granted 250,000 options
@ $0.4, valued at
$100k
|
|
| 04/29/2019 |
3
| Horne William B (CEO) has filed a Form 3 on Medovex Corp. |
| 01/12/2018 |
4
| Crowne Jesse (Director) has filed a Form 4 on Medovex Corp.|
Txns:
| Granted 10,407 shares
@ $0.55, valued at
$5.7k
|
|
| 01/05/2018 |
4
| Crowne Jesse (Director) has filed a Form 4 on Medovex Corp.|
Txns:
| Granted 4,093 shares
@ $0.55, valued at
$2.3k
|
|
| 01/02/2018 |
4
| Betz Randal R (Director) has filed a Form 4 on Medovex Corp.|
Txns:
| Granted 9,650 shares
@ $0.558, valued at
$5.4k
Granted 350 shares
@ $0.521, valued at
$182.4 |
|
|
|
|